ER General Note

Subjective:
Chief Complaint:
Follow-up for insulin resistance, thyroid function, menopausal symptoms, vaginal dryness, and changes in menstrual patterns.

History of Present Illness:
Maria Santos, a 48-year-old female, presents for follow-up regarding her ongoing management of insulin resistance, thyroid function, and hormonal therapy. She reports adherence to her prescribed regimen, including berberine, which she states has positively impacted her fasting glucose levels, now ranging between 79 and 94 mg/dL. She denies any adverse reactions to berberine. She is not currently taking Vitamin D supplementation and notes no significant change in mental clarity. She reports persistent vaginal dryness despite ongoing treatment and denies urinary incontinence. She has not experienced menstruation since November but mentions a recent occurrence of a small, dry clot. She denies any issues with her current thyroid medication and reports no adverse effects. She is compliant with her prescribed medications and supplements and monitors her glucose levels regularly.

Past Medical History:
She has a history of insulin resistance, for which she has been managed with berberine and other supplements. She has demonstrated consistent compliance with her prescribed medications and supplements, including regular monitoring of her blood glucose levels. She has a history of thyroid dysfunction, currently managed with thyroid hormone replacement therapy, and has tolerated adjustments in her regimen without adverse effects. She has also been undergoing hormonal therapy for menopausal symptoms, including persistent vaginal dryness. She has not reported any missed appointments or non-compliance with her treatment plan. She has not experienced any hospitalizations, emergency department visits, or significant injuries in the past. She has not reported any significant past medical history of other chronic diseases. She has not reported any history of smoking or alcohol use. She has not reported any known allergies. She has not reported any family history of specific conditions.

Family History:
She has no family history of specific conditions mentioned that are relevant to her current complaints of insulin resistance, thyroid dysfunction, or hormonal therapy.

Social History:
- Tobacco: Never smoked
- Alcohol: No alcohol use mentioned
- Drug Use: Not mentioned
- Occupation: Not mentioned
- Living Situation: Not mentioned

The Review of Systems:
- General: She reports no significant change in mental clarity. No fatigue, weight changes, or behavioral changes reported.
- Head: Not mentioned
- Eyes: Not mentioned
- Ears: Not mentioned
- Throat: Not mentioned
- Nose: Not mentioned
- Cardiovascular: Not mentioned
- Respiratory: Not mentioned
- Gastrointestinal: Not mentioned
- Genitourinary: She reports persistent vaginal dryness despite ongoing treatment. She denies urinary incontinence. She has not experienced menstruation since November, with the exception of a recent small, dry clot.
- Musculoskeletal: Not mentioned
- Neurological: She reports no significant change in mental clarity.
- Integumentary: Not mentioned
- Psychiatric: Not mentioned
- Hematologic: Not mentioned
- Lymphatic: Not mentioned
- Endocrine: She is being managed for insulin resistance and thyroid dysfunction. She denies adverse reactions to berberine.
- Allergy and Immunology: Not mentioned

Past Surgical History:
She has not undergone any surgical procedures in the past.

Current Medications:
She is currently taking berberine, which has positively impacted her fasting glucose levels. She is also taking a thyroid medication (Alora, previously at 60 mcg, now increased to 90 mcg). She is not currently taking Vitamin D supplementation. She is using topical DHEA for vaginal dryness. She is compliant with her prescribed medications and supplements.

Allergies:
She has no known allergies mentioned.

Objective:
Vital Signs:
Temp , HR , BP , RR , SpO2 

Physical Examination:
General: She appears in no acute distress.
HEENT: Not assessed
Cardiovascular: Not assessed
Respiratory: Not assessed
Gastrointestinal: Not assessed
Genitourinary: She reports persistent vaginal dryness. No urinary incontinence.
Musculoskeletal: Not assessed
Neurological: Not assessed
Integumentary: Not assessed

Test Results:
- Lab:
  - No abnormal findings in recent blood sugar levels.
  - No significant abnormalities in recent laboratory results except for noted deficiencies.
  - Fasting glucose levels: 79-94 mg/dL.
  - Insulin level: 17 (goal is less than 7).
  - DHEA: 70 (low).
  - Free T3: 2.53 (low-normal).
  - Estradiol: 66.
  - FSH: 7.27.
  - Total testosterone: 195.
  - Sex hormone binding globulin: 63.
- Imaging:
- EKG:

Assessment:
Summary Statement:
She is a 48-year-old female with a history of insulin resistance, thyroid dysfunction, and hormonal therapy, presenting for follow-up. Her fasting glucose levels have improved with berberine. She continues to experience persistent vaginal dryness despite topical DHEA. Laboratory evaluation reveals low DHEA and suboptimal free T3. Her thyroid medication dosage has been increased, and supplementation with DHEA and Vitamin D is recommended. She remains compliant with her medications and demonstrates no adverse reactions. Further monitoring and adjustment of her regimen are planned.

Reassessment Note:
Time Interval: 

Symptom Changes and Response to Interventions: She continues to report persistent vaginal dryness despite ongoing topical DHEA therapy. No new symptoms have developed. She denies adverse reactions to current medications. Her fasting glucose remains well controlled.

Vital Signs: Temp , HR , BP , RR , SpO2 

Physical Exam: No acute changes noted. Persistent vaginal dryness remains the primary concern.

New Test Results: No new test results since initial assessment.

Updated Plan:

- Further tests: Repeat laboratory evaluation of hormonal profile and metabolic parameters as clinically indicated.
- Further treatment: Increase Alora dosage to 90 mcg. Initiate oral DHEA supplementation and Vitamin D as recommended.
- Disposition: Outpatient follow-up.
- Follow up: She is to follow up as scheduled for reassessment and further management.